Cooper-Vemedia Pays €158m for Sanofi Brands

European OTC drug manufacturer and distributor Cooper-Vemedia has acquired a portfolio of 12 pharmaceutical brands from Sanofi for €158m.

The acquisition is part of Cooper-Vemedia’s strategy to build a pan-European business focused on OTC medicines.

The Sanofi portfolio includes dermatology, well-being and eye care products sold mainly in France and Italy, but also exported to other world markets. Sanofi has sold the brands to reduce the complexity of its portfolio and focus on its core business segments; pain, allergy, coughs and colds, digestive health and nutrition.

Chief executive of Cooper-Vemedia, Francis Doblin, said the brands “enjoy leading market positions and high consumer awareness and would strengthen Cooper-Vemedia’s position in Europe.”